US FDA approves Casgevy, cell-based gene therapy to treat transfusion-dependent beta-thalassemia
The approval signifies a second FDA-approved indication for Casgevy, as the product was also recently approved for the treatment…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
cell-based gene therapy
FDA approves Tecartus, cell-based gene therapy to treat relapsed or refractory MCL in adults
It also received ‘Orphan Drug’ designation, which provides incentives to assist and encourage the development of drugs for rare…